Pfizer, Starboard
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.
Pfizer Went From Covid Star to Activist Target as Stock Fell (1)
Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to lose.
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Activist investor Starboard has informed Pfizer it has taken a stake
Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.
Activist investor Starboard cries foul play in exec U-turn at Pfizer
Starboard has accused Pfizer of “coercive conduct” after executives who initially backed the hedge fund retracted their support.
Former Pfizer executives not involved in Starboard's campaign against drugmaker
CFO Frank D'Amelio said in a statement that they will not be involved with activist investor Starboard Value, which wants the U.S. drug giant to make changes to turn its performance around. "We are fully supportive of Pfizer Chairman and CEO Albert Bourla,
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Guggenheim caught in Starboard-Pfizer crossfire
Now, despite playing no formal role in the battle between Pfizer and Starboard, Guggenheim has found itself in the crossfire of one of the messiest activist campaigns in recent Wall Street memory.
STAT4d
Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Pfizer Threatened Ex-CEO Over Work With Activist, Starboard Says
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
Pfizer CEO Bourla To Meet Activist Investor Starboard, Report Says
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
https//insights.som.yale.edu1d
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...